← Back to Search

Trending Feedback for Acute Respiratory Infection

N/A
Waitlist Available
Led By Daniella Meeker, PhD
Research Sponsored by University of Southern California
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

Study Summary

This trial will test if antibiotic prescribing can be reduced in a telehealth environment by using insights from decision and social psychology.

Eligible Conditions
  • Acute Respiratory Infection
  • Telemedicine

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in antibiotic prescribing rate for Acute Respiratory Infections
Secondary outcome measures
Change in inappropriate antibiotic prescribing rate for Acute Respiratory Infections

Trial Design

9Treatment groups
Experimental Treatment
Active Control
Group I: Trending Feedback + Public CommitmentExperimental Treatment2 Interventions
Clinicians receive both Trending Feedback + Public Commitment interventions.
Group II: Trending Feedback + Private CommitmentExperimental Treatment2 Interventions
Clinicians receive both Trending Feedback + Private Commitment interventions.
Group III: Trending Feedback + Commitment ControlExperimental Treatment1 Intervention
Clinicians receive Trending Feedback intervention + Commitment Control.
Group IV: Public Commitment + Feedback ControlExperimental Treatment1 Intervention
Clinicians receive Public Commitment intervention + Feedback Control.
Group V: Private Commitment + Feedback ControlExperimental Treatment1 Intervention
Clinicians receive Private Commitment intervention + Feedback Control.
Group VI: Benchmark Peer Comparison Feedback + Public CommitmentExperimental Treatment2 Interventions
Clinicians receive both Benchmark Peer Comparison Feedback + Public Commitment interventions.
Group VII: Benchmark Peer Comparison Feedback + Private CommitmentExperimental Treatment2 Interventions
Clinicians receive both Benchmark Peer Comparison Feedback + Private Commitment interventions.
Group VIII: Benchmark Peer Comparison Feedback + Commitment ControlExperimental Treatment1 Intervention
Clinicians receive Benchmark Peer Comparison Feedback intervention + Commitment Control.
Group IX: Commitment Control + Feedback ControlActive Control1 Intervention
Clinicians receive no intervention.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Trending Feedback
2022
N/A
~6590
Public Commitment
2022
N/A
~6590
Private Commitment
2022
N/A
~6590
Benchmark Peer Comparison Feedback
2022
N/A
~6590

Find a Location

Who is running the clinical trial?

University of Southern CaliforniaLead Sponsor
905 Previous Clinical Trials
1,589,697 Total Patients Enrolled
Agency for Healthcare Research and Quality (AHRQ)FED
399 Previous Clinical Trials
6,815,767 Total Patients Enrolled
Teladoc HealthIndustry Sponsor
1 Previous Clinical Trials
200 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment in the trial still available for those seeking treatment?

"The records on clinicaltrials.gov confirm that this trial, which was initially listed in March 2022 is not presently enrolling patients. Nonetheless, there are 93 other medical research studies open for recruitment at the moment."

Answered by AI
Recent research and studies
BmjJournal
Appropriateness of Outpatient Antibiotic Prescribing Among Privately Insured US Patients: ICD-10-CM Based Cross Sectional Study
Chua, Kao-Ping, Michael A Fischer, and Jeffrey A Linder. 2019. “Appropriateness of Outpatient Antibiotic Prescribing Among Privately Insured US Patients: ICD-10-CM Based Cross Sectional Study”. Bmj. BMJ. doi:10.1136/bmj.k5092.
JAMA Internal MedicineJournal
Nudging Guideline-concordant Antibiotic Prescribing
Meeker, Daniella, Tara K. Knight, Mark W. Friedberg, Jeffrey A. Linder, Noah J. Goldstein, Craig R. Fox, Alan Rothfeld, Guillermo Diaz, and Jason N. Doctor. 2014. “Nudging Guideline-concordant Antibiotic Prescribing”. JAMA Internal Medicine. American Medical Association (AMA). doi:10.1001/jamainternmed.2013.14191.
JamaJournal
Effect of Behavioral Interventions on Inappropriate Antibiotic Prescribing Among Primary Care Practices
Meeker, Daniella, Jeffrey A. Linder, Craig R. Fox, Mark W. Friedberg, Stephen D. Persell, Noah J. Goldstein, Tara K. Knight, Joel W. Hay, and Jason N. Doctor. 2016. “Effect of Behavioral Interventions on Inappropriate Antibiotic Prescribing Among Primary Care Practices”. Jama. American Medical Association (AMA). doi:10.1001/jama.2016.0275.
MMWR. Recommendations and ReportsJournal
Core Elements of Outpatient Antibiotic Stewardship
Sanchez, Guillermo V., Katherine E. Fleming-Dutra, Rebecca M. Roberts, and Lauri A. Hicks. 2016. “Core Elements of Outpatient Antibiotic Stewardship”. MMWR. Recommendations and Reports. Centers for Disease Control MMWR Office. doi:10.15585/mmwr.rr6506a1.
~2134 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top